PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404

NCT01540513 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme
Brain Metastases

Interventions

DRUG: NM404
DRUG: NM404

Sponsor

University of Wisconsin, Madison